The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences

作者:

DOI: 10.1007/S13596-020-00476-0

关键词:

摘要: The objective of the present study was to evaluate effect Berberis aristata (BA) against oxazolone induced contact dermatitis in Balb/c mice and molecular docking with TLR-1 TLR-2. Dermatitis by sensitizing topical application 100 μl (2%) BA screened two doses (200 mg/kg 400 mg/kg P.O.). evaluated change ear thickness, anti-inflammatory cytokine (TNF-α, IL-6, IL-1β) oxidative stress on sixth day tissue homogenate. skin all group subjected histological analysis. This work further evidenced berberine crystal structure TLR1-TLR2 heterodimer caused using binding tri-acylated lipopeptide (PDB ID: 2Z7X). In this study, we found that a significant reduction thickness 400 mg/kg) as compared oxazolone(2%) treated mice. level GSH SOD sensitized animals showed an increase levels. A inflammatory cytokines observed indicates activity oxazolone. Histopathological analysis minimal infiltration lymphocytes moderate harm cells layer Docking studies revealed promising interaction withTLR1-TLR2 which can attribute its anti dermatic effect. research shows has dose-dependent attenuated

参考文章(25)
Dipti Potdar, R.R. Hirwani, Sivakami Dhulap, Phyto-chemical and pharmacological applications of Berberis aristata. Fitoterapia. ,vol. 83, pp. 817- 830 ,(2012) , 10.1016/J.FITOTE.2012.04.012
Tao Zheng, Min H. Oh, Sun Y. Oh, John T. Schroeder, Adam B. Glick, Zhou Zhu, Transgenic Expression of Interleukin-13 in the Skin Induces a Pruritic Dermatitis and Skin Remodeling Journal of Investigative Dermatology. ,vol. 129, pp. 742- 751 ,(2009) , 10.1038/JID.2008.295
Yasutomo Fujii, Hiroko Takeuchi, Keiko Tanaka, Shozo Sakuma, Yoshitaka Ohkubo, Seitaro Mutoh, Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats European Journal of Pharmacology. ,vol. 456, pp. 115- 121 ,(2002) , 10.1016/S0014-2999(02)02554-2
Emanuela Corsini, Corrado L Galli, Epidermal cytokines in experimental contact dermatitis. Toxicology. ,vol. 142, pp. 203- 212 ,(2000) , 10.1016/S0300-483X(99)00145-6
Michelle A. Lowes, Chris B. Russell, David A. Martin, Jennifer E. Towne, James G. Krueger, The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends in Immunology. ,vol. 34, pp. 174- 181 ,(2013) , 10.1016/J.IT.2012.11.005
Thomas K. Petersen, In vivo Pharmacological Disease Models for Psoriasis and Atopic Dermatitis in Drug Discovery Basic & Clinical Pharmacology & Toxicology. ,vol. 99, pp. 104- 115 ,(2006) , 10.1111/J.1742-7843.2006.PTO_298.X
Yong-Wook Shin, Eun-Ah Bae, Sung-Soo Kim, Young-Chul Lee, Dong-Hyun Kim, Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. International Immunopharmacology. ,vol. 5, pp. 1183- 1191 ,(2005) , 10.1016/J.INTIMP.2005.02.016
Ágnes Kemény, Dóra Reglődi, Renáta Cseharovszky, Hitoshi Hashimoto, Akemichi Baba, János Szolcsányi, Erika Pintér, Zsuzsanna Helyes, Pituitary Adenylate Cyclase-Activating Polypeptide Deficiency Enhances Oxazolone-Induced Allergic Contact Dermatitis in Mice Journal of Molecular Neuroscience. ,vol. 42, pp. 443- 449 ,(2010) , 10.1007/S12031-010-9368-3
Emma Guttman-Yassky, Kristine E. Nograles, James G. Krueger, Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts The Journal of Allergy and Clinical Immunology. ,vol. 127, pp. 1110- 1118 ,(2011) , 10.1016/J.JACI.2011.01.053